J
Jane M. Andrews
Researcher at Royal Adelaide Hospital
Publications - 329
Citations - 14638
Jane M. Andrews is an academic researcher from Royal Adelaide Hospital. The author has contributed to research in topics: Inflammatory bowel disease & Medicine. The author has an hindex of 48, co-authored 298 publications receiving 12270 citations. Previous affiliations of Jane M. Andrews include St. Vincent's Health System & Health Science University.
Papers
More filters
Journal ArticleDOI
597 Serological Antibodies for the Prediction of Post-Operative Recurrent Crohn's Disease Results From the POCER Study
Amy L. Hamilton,Michael A. Kamm,Fabiyola Selvaraj,Fred Princen,Peter De Cruz,Emily K Wright,Kathryn J. Ritchie,Efrosinia O. Krejany,Alexandra Gorelik,Danny Liew,Lani Prideaux,Ian C. Lawrance,Jane M. Andrews,Peter A. Bampton,Miles P. Sparrow,Timothy H. Florin,Peter R. Gibson,H.S. Debinski,Richard B. Gearry,Finlay A. Macrae,Rupert W. Leong,Ian Kronborg,Graham L. Radford-Smith,Warwick Selby,Michael J. Johnston,Rodney Woods,Peter R. Elliott,Sally Bell,Steven J. Brown,William Connell,Paul V. Desmond,Sharat Singh +31 more
Journal ArticleDOI
Transfusion strategies in upper gastrointestinal bleeding management: a review of South Australian hospital practice.
TL;DR: A large single‐centre randomised study from 2013 showed that a restrictive transfusion strategy in UGIB management was associated with better outcomes compared to a liberal strategy, but generalisation to everyday practice was unclear.
Journal ArticleDOI
Tu1844 Symptom Stability and Economic Burden in Patients With Functional Dyspepsia: Observational 12 Month Follow-Up After a Short-Term Clinical Trial
Amelia N. Pilichiewicz,Gerald Holtmann,Charlotte Goess,Richard H. Holloway,Robert J. Fraser,Justin Beilby,Nicholas J. Talley,Jane M. Andrews +7 more
TL;DR: The number of duodenal neuroendocrine cells is decreased in FD compared with control subjects, but it is possible that this reduction reflects reduced cellular densities of other hormones which could result in a high secretion of gastric acid, with a change in motility or visceral sensitivity leading to dyspeptic symptoms in these cases.
Journal ArticleDOI
Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease
Alex Barnes,S. Ooi,Kate D. Lynch,Nina Parthasarathy,Maria Bishara,M P Gounder,Rachel Grafton,Peta Leach,Peter A. Bampton,Alexandra Sechi,Watson Ng,Susan J. Connor,D. R. Van Langenberg,Réme Mountifield,Jane M. Andrews +14 more
TL;DR: In this article , a multicenter retrospective observational study of outcomes post thiopurine TDM was conducted, which included 541 patients with inflammatory bowel disease (IBD) at baseline and at 12 months.
Journal ArticleDOI